Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis

Journal of Bone and Mineral Research

Volumn 11, Issue 3, 1996, Pages 337-349

  Garnero, Patrick ^a   Sornay Rendu, Elizabeth ^a   Chapuy, Marie Claire ^a   Delmas, Pierre D ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; COLLAGEN TYPE 1; FOLLITROPIN; OSTEOCALCIN; PROTEIN C;

ADULT; AGED; AGING; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MASS; BONE MINERAL; BONE TURNOVER; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; HUMAN EXPERIMENT; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; SECONDARY HYPERPARATHYROIDISM;

EID: 0029928837     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.5650110307     Document Type: Article

References (48)

1. Melton III LJ, Atkinson EJ, O'Fallon WM, Wahner HW. Riggs BL 1993 Long-term fracture prediction by bone mineral assessed at different skeletal sites. J Bone Miner Res 8:1227-1233.
2. Black DM, Cummings SR, Genant HK, Nevitt MC. Palermo L, Browner WS 1992 Axial bone density predicts fractures in older women. J Bone Miner Res 7:633-638.
3. Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S. Delmas PD. Meunier PJ 1992 Vitamin D3 and calcium to prevent hip fractures in elderly women. New Engl J Med 327:1637-1642.
4. Jones G, Nguyen T, Kelly PJ, Eisman JA 1994 Progressive loss of bone in the femoral neck in elderly people: Longitudinal findings from the Dubbo osteoporosis epidemiology study. Br Med J 309:691-695.
5. Lips P. Courpron P, Meunier PJ 1978 Mean wall thickness of trabecular bone packets in the human iliac crest: Changes with age. Calcif Tissue Res 26:13-17.
6. Parfitt AM, Mathews CHE, Villanueva AR, Kleerekoper M, Frame B. Rao DS 1983 Relationship between surface, volume and thickness of iliac trabecular bone in aging and in osteoporosis. J Clin Invest 72:1396.
7. Arlot M, Edouard C, Meunier PJ, Neer RM. Reeve J 1984 Impaired osteoblast function in osteoporosis: comparison between calcium balance and dynamic histomorphometry. Br Med J 289:517-520.
8. Eastell R, Delmas PD, Hodgson SF, Ericksen EF, Mann KG, Riggs BL 1988 Bone formation rate in older normal women: Concurrent assessment with bone histomorphometry, calcium kinetics and biochemical markers. J Clin Endocrinol Metabol 67:741-748.
9. Delmas PD, Stenner D, Wahner HW, Mann KG, Riggs BL 1983 Increase in serum bone γ-carboxyglutamic acid protein with aging in women. J Clin Invest 71:1316-1321.
10. Kelly PJ, Pocock NA. Sambrook PN, Eisman JA 1989 Age and menopause-related changes in indices of bone turnover. J Clin Endocrinol Metab 69:1160-1165.
11. Stepan JJ, Pospichal J, Presl J, Pacovsky V 1987 Bone loss and biochemical indices of bone remodeling in surgically postmenopausal women. Bone 8:279-284.
12. Garnero P, Grimaux M, Demiaux B, Préaudat C, Seguin P, Delmas PD 1992 Measurement of serum osteocalcin with a human-specific two-site radioimmunoassay. J Bone Miner Res 7:1389-1397.
13. Garnero P, Delmas PD 1993 Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. J Clin Endocrinol Metab 77:1046-1053.
14. Delmas PD 1993 Biochemical markers of bone turnover. J Bone Miner Res. 8 (Suppl 2):S549-S554.
15. Eyre DR, Koob TJ, Van Neww KP 1984. Quantitation of hydroxypyridinium cross links in collagen by high performance liquid chromatography. Anal Biochem 137:380-388.
16. Black D, Buncan A, Robins SP 1989 Quantitative analysis of pyridinium cross links of collagen in urine using ion-paired reversed-phase high performance chromatography. Anal Biochem 169:197-203.
17. Uebelhart D, Gineyts E, Chapuy MC, Delmas PD 1990 Urinary excretion of pyridinium cross links: A new marker of bone resorption in metabolic bone disease. Bone Miner 8:87-96.
18. Robins SP, Black D, Paterson CR, Reid DM, Duncan A, Seibel MJ 1991 Evaluation of urinary hydroxypyridinium cross link measurements as resorption markers in metabolic bone disease. Eur J Clin Invest 21:310-315.
19. Delmas PD, Schlemmer A, Gineyts E. Riis B, Christiansen C 1991 Urinary excretion of pyndinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis. J Bone Miner Res 6:639-644.
20. Seyedin SM, Kung VT. Daniloff YN, Hesley RP, Gomez B. Nielsen LA, Rosen H, Zuk RF 1993 Immunoassay for urinary pyridinoline. The new marker of bone resorption. J Bone Miner Res 8:635-641.
21. Hanson DA. Weis MAE, Bollen AM, Maslan SH, Singer FR. Eyre DR 1992 A specific immunoassay for monitoring human bone resorption: Quantitation of Type 1 collagen cross linked N-telopeptides in urine. J Bone Miner Res 7:1251-1258.
22. Garnero P, Gineyts E, Riou JP, Delmas PD 1994 Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease. J Clin Endocrinol Metab 79:780-785.
23. Garnero P, Shih W, Gineyts E, Karpf DB, Delmas PD 1994 Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 79:1693-1700.
24. Garnero P, Grimaux M, Seguin P, Delmas PD 1994 Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro. J Bone Miner Res 9:255-264.
25. Winterbottom N, Vernon S, Freeman K, Daniloff G, Seyedin S 1993 A serum immunoassy for the C-terminal propeptide of type I collagen. J Bone Miner Res 8 (Suppl 1):S341 (abstract).
26. Sherman BM, West JH, Korenman SG 1975 Hormonal characteristics of the human menstrual cycle throughout reproductive life. J Clin Invest 55:699-706.
27. Sherman BM, West JH. Korenman SG 1976 The menopausal transition: Analysis of LH, FSH, estradiol and progesterone concentrations during the menstrual cycles of older women. J Clin Endocrinol Metab 42:629-636.
28. Goldberg RL, Grodin JM. Rodbard D, Ross GT 1973 Gonadotrophins in women with amenorrhea: Use of plasma folliclestimulating hormone to differentiate women with and without ovarian follicles. Am J Obstet Gynecol 116:1003-1012.
29. Johnston CC, Hui SL. Witt RM. Applendorn R, Baker RS, Longcope C 1985 Early menopausal changes in bone mass and sex steroids. J Clin Endocrinol Metab 61:905-911.
30. Steinberg KK, Freni-Titulaer LW, DePuey EG, et al. 1989 Sex steroids and bone density in premenopausal and perimenopausal women. J Clin Endocrinol Metab 69:533-539.
31. Nilas L, Chrsitiansen C 1989. The pathophysiology of peri- and postmenopausal bone loss. Br J Obstet Gynaecol 96:580-587.
32. Heaney RP, Recker RR, Saville RP 1978 Menopausal changes in bone remodeling. J Lab Clin Med 92:964-970.
33. Hassager C, Fabbri-Mabelli G, Christiansen C 1993 The effect of the menopause and hormone replacement therapy on serum carboxyterminal propeptide of Type 1 collagen. Osteoporosis Int 3:50-52.
34. Ebeling PR, Peterson JM, Riggs BL 1992 Utility of type 1 procollagen assays for assessing abnormalities in metabolic bone diseases. J Bone Miner Res 7:1243-1250.
35. Smedsrod B, Melko J, Risteli L, Risteli J 1990 Circulating C-terminal propeptide of type 1 procollagen is cleared mainly via the mannose receptor in liver endothelial cells. Biochem J 271:345-350.
36. Delmas PD, Wilson DM, Mann KG, Riggs BL 1983 Effect of renal function on plasma levels of bone GLA-protein. J Clin Endocrinol Metab 57:1028-1030.
37. Beardsworth LJ, Eyre DR, Dickson IR 1990 Changes with age in the urinary excretion of lysyl and hydroxylysylpyridinoline, two new markers of bone collagen turnover. J Bone Miner Res 5:671-676.
38. Epstein S, Poser J, McClintock R, Johnston Jr CC, Bryce G, Hui S 1984 Differences in serum bone gla protein with age and sex. Lancet 2:307-310.
39. Duda RJ, O'Brien JF, Katzmann JA, Peterson JM, Mann KG, Riggs BL 1988 Concurrent assays of circulating bone glaprotein and bone alkaline phosphatase: Effects of sex, age. and metabolic bone disease. J Clin Endocrinol Metab 66: 951-957.
40. Garcia-Carrasco M, Gruson M, De Vernejoul MC, Denne MA, Miravet L 1988 Osteocalcin and bone morphometric parameters in adults without bone disease. Calcif Tissue Int 42:13-17.
41. Price PA, Pathermore JG, Deftos LJ 1980 New biochemical marker for bone metabolism: measurement by radioimmunoassay for bone GLA-protein in the plasma of normal subjects and in patients with bone disease. J Clin Invest 66:878-883.
42. Johansen J, Riis BJ, Delmas PD, Christiansen C 1988 Plasma BGP: an indicator of spontaneous bone loss and the effect of estrogen treatment in postmenopausal women. Eur J Clin Invest 18:191-195.
43. Uebelhart D. Schlemmer A, Johansen JS, Gineyts E, Christiansen C, Delmas PD 1991 Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links. J Clin Endocrinol Metab 72:367-373.
44. Hansen MA, Kirsten O, Riis BJ, Christiansen C 1991 Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 years study. Br Med J 303:961-964.
45. Prestwood KM, Pilbeam CC, Burleson JA, Woodiel FN, Delmas PD, Deftos LJ. Raisz LG 1994 The short term effects of conjugated estrogen on bone turnover in older women. J Clin Endocrinol Metab 79:366-371.
46. Gallagher JC, Riggs BL, Eisman J, Hamstra A, Arnaud SB, DeLuca HF 1979 Intestinal absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients; effect of age and dietary calcium. J Clin Invest 64:729-736.
47. Bell NH 1995 Vitamin D metabolism, aging, and bone loss. J Clin Endocrinol Metab 80:1051.
48. Riggs BL, Melton III LJ 1983 Evidence for two distinct syndromes of involutional osteoporosis. Am J Med 75:899-901.